Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05879302 · ClinicalTrials.gov registry record · NA
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
A NA study of End Stage Renal Disease and Kidney Transplantation, sponsored by Hennepin Healthcare Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT05879302: Recruiting NA study of End Stage Renal Disease and Kidney Transplantation, sponsored by Hennepin Healthcare Research Institute.
NCT05879302 is a NA study of End Stage Renal Disease and Kidney Transplantation that is actively recruiting participants, run by Hennepin Healthcare Research Institute. The registered enrollment target is 100 participants, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05879302, a NA study of End Stage Renal Disease and Kidney Transplantation, is actively recruiting participants, sponsored by Hennepin Healthcare Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this pilot randomized trial is to learn about shared decision making in kidney transplant candidates. The aim of this proposal is to evaluate the Donor Plan Donor Choice tool to promote high-quality Shared Decision Making for providers and kidney transplant candidates at two transplant centers. Participants will: * Review an online education tool, Donor Plan Donor Choice. * Discuss a Kidney Offer Plan with a transplant provider. * Answer questions about willingness to consider different donor types. Researchers will compare the Shared Decision Making group to usual care to generate pilot data and implementation outcomes for a larger trial.
Primary Outcome
Willingness to accept a donor kidney offer will be measured by three items on a 5-point Likert scale anchored by "strongly agree" and "strongly disagree." Willingness to accept will be defined by answers of "agree" or "strongly agree."
Conditions Studied
Interventions
- BEHAVIORAL Kidney Offer Shared Decision Making
Study Locations (2)
Minnesota
- Hennepin Healthcare - Minneapolis
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-04-03 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What NCT05879302 shows while recruiting
NCT05879302 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 832-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (88% lower).
The record links to 4 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Kidney Offer Shared Decision Making is the first listed.
NCT05879302 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05879302 about?
NCT05879302 is a clinical study titled "Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision". The goal of this pilot randomized trial is to learn about shared decision making in kidney transplant candidates. The aim of this proposal is to evaluate the Donor Plan Donor Choice tool to promote high-quality Shared Decision Making for providers and kidney transplant candidates at two transplant c...
What is the current status of trial NCT05879302?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-04-03. Estimated completion is 2025-11-30.
What conditions does trial NCT05879302 study?
This clinical trial studies the following conditions: End Stage Renal Disease, Kidney Transplantation, End-Stage Kidney Disease, ESRD.
What interventions are being tested in trial NCT05879302?
The interventions under investigation include: Kidney Offer Shared Decision Making (BEHAVIORAL).
Who is sponsoring clinical trial NCT05879302?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05879302 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05879302's enrollment target sits among peer trials
100 34th of 86 higher than 50 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
RECRUITING · NA
-
CAPABLE Transplant
RECRUITING · NA
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
RECRUITING · NA
-
Solv Multi-Pass Hemodialysis System In-Center Clinical Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI